Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Arati Desai"'
Autor:
Laiz Laura de Godoy, Suyash Mohan, Sumei Wang, MacLean P. Nasrallah, Yu Sakai, Donald M. O’Rourke, Stephen Bagley, Arati Desai, Laurie A. Loevner, Harish Poptani, Sanjeev Chawla
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background Accurate differentiation of pseudoprogression (PsP) from tumor progression (TP) in glioblastomas (GBMs) is essential for appropriate clinical management and prognostication of these patients. In the present study, we sought to val
Externí odkaz:
https://doaj.org/article/939f563d0d71422b9916e708c2031dea
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-6 (2020)
Abstract A case of a true dual-genotype IDH-mutant oligoastrocytoma with two different cell types within a single mass in a young woman is presented. Imaging findings of the left frontal infiltrating glioma predicted the two neoplastic components tha
Externí odkaz:
https://doaj.org/article/0dc07ca25d1f42129bba5591f20a4627
Autor:
MacLean P. Nasrallah MD, PhD, Zev A. Binder MD, PhD, Derek A. Oldridge MD, PhD, Jianhua Zhao PhD, FACMG, David B. Lieberman MS, CGC, Jacquelyn J. Roth PhD, Christopher D. Watt MD, PhD, Shrey Sukhadia MS, Eva Klinman PhD, Robert D. Daber PhD, Arati Desai MD, Steven Brem MD, Donald M. O’Rourke MD, Jennifer J. D. Morrissette PhD
Publikováno v:
Academic Pathology, Vol 6 (2019)
Molecular profiling of glioblastoma has revealed complex cytogenetic, epigenetic, and molecular abnormalities that are necessary for diagnosis, prognosis, and treatment. Our neuro-oncology group has developed a data-driven, institutional consensus gu
Externí odkaz:
https://doaj.org/article/d2e4dd6467f7414987f25784371d72bc
Autor:
Cameron J. Koch, Robert A. Lustig, Xiang-Yang Yang, Walter T. Jenkins, Ronald L. Wolf, Maria Martinez-Lage, Arati Desai, Dewight Williams, Sydney M. Evans
Publikováno v:
Translational Oncology, Vol 7, Iss 6, Pp 752-758 (2014)
The standard of care for glioblastoma (GB) is surgery followed by concurrent radiation therapy (RT) and temozolomide (TMZ) and then adjuvant TMZ. This regime is associated with increased survival but also increased occurrence of equivocal imaging fin
Externí odkaz:
https://doaj.org/article/67db5518250f4c009e1718e201a41d9a
Autor:
Laiz Laura de Godoy, Sanjeev Chawla, Steven Brem, Sumei Wang, Donald M O’Rourke, MacLean P. Nasrallah, Arati Desai, Laurie A. Loevner, Linda M. Liau, Suyash Mohan
Publikováno v:
Journal of Neuro-Oncology. 163:173-183
Purpose Autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) is a promising treatment modality for glioblastomas. The purpose of this study was to investigate the potential utility of multiparametric MRI-based prediction model in evaluatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f9560e2f6bdacee2dd2eccd036f946
https://doi.org/10.1007/s11060-023-04324-4
https://doi.org/10.1007/s11060-023-04324-4
Autor:
Shawn Kothari, Anna C Dusenbery, Abigail Doucette, Daniel Y Zhang, Dominique Ballinger, Arati Desai, Jennifer J D Morrissette, Stephen J Bagley, MacLean P Nasrallah
Publikováno v:
Neuro-Oncology Practice.
Background Recurrent gliomas are therapeutically challenging diseases with few treatment options available. One area of potential therapeutic vulnerability is the presence of targetable oncogenic fusion proteins. Methods To better understand the clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01279dcbd707b8abd30ecbc0ff70ee2d
https://doi.org/10.1093/nop/npad022
https://doi.org/10.1093/nop/npad022
Autor:
Maria A Gubbiotti, Kiratpreet Singh Dhillon, Jaryse Harris, Shawn Kothari, Jeffrey B Ware, Arati Desai, Jacob Shabason, Markku Miettinen, Martha Quezado, Kenneth Aldape, Kevin Judy, Zi-Xuan Wang, Mark T Curtis, MacLean P Nasrallah
Publikováno v:
Journal of Neuropathology & Experimental Neurology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7b1653b9fc54a207255e1b5f203b469
https://doi.org/10.1093/jnen/nlad032
https://doi.org/10.1093/jnen/nlad032
Autor:
Patrick Wen, Caroline Duault, Edgar Gonzalez-Kozlova, Kevin Brennan, Tyson Holmes, Seunghee Kim-Schulze, Kai Nie, Kimberly Argueta, Jacques Fehr, Mina Pichavant, Diane Del Valle, Andrew Gentles, Sacha Gnjatic, Holden Maecker, Xiaobu Ye, David Reardon, Wenya Linda Bi, Pierpaolo Peruzzi, Nirav Patel, Roy Strowd, Stephen Tatter, Ian Lee, Tobias Walbert, James Snyder, Steven Brem, Arati Desai, Stephen Bagley, Nduka Amankulor, Frank Lieberman, Megan Mantica, Lenika Lopez, Susan Bell, Andrea Manzanera, Sean Lawler, Lixian Jin, Neeraja Danda, Serena Desideri, L Burt Nabors, Stuart Grossman, E Chiocca, Paul Tak, Francesca Barone
Publikováno v:
Late-Breaking Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeab66abcbc189d92953a16f29859e54
https://doi.org/10.1136/jitc-2022-sitc2022.1477
https://doi.org/10.1136/jitc-2022-sitc2022.1477
Autor:
Ali, Nabavizadeh, Stephen J, Bagley, Robert K, Doot, Jeffrey B, Ware, Anthony J, Young, Satyam, Ghodasara, Chao, Zhao, Hannah, Anderson, Erin, Schubert, Erica L, Carpenter, Jacob, Till, Fraser, Henderson, Austin R, Pantel, H Isaac, Chen, John Y K, Lee, Nduka M, Amankulor, Donald M, O'Rourke, Arati, Desai, MacLean P, Nasrallah, Steven, Brem
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cce20a888b789a78cc790936f71d22f1
https://pubmed.ncbi.nlm.nih.gov/36549916
https://pubmed.ncbi.nlm.nih.gov/36549916
Autor:
Fabio Iwamoto, Shyam Tanguturi, Arati Desai, Lakshmi Nayak, Erik Uhlmann, Tony Wang, Robert Lustig, Lauren Hertan, Stephen Bagley, Julia Hayden, Corey Laforest-Roys, Alona Muzikansky, Christine McCluskey, Ugonma Chukwueke, J Ricardo McFaline-Figueroa, Eudocia Lee, Patrick Y Wen, David Reardon
Publikováno v:
Neuro-Oncology. 24:vii63-vii64
Re-irradiation is therapeutically considered for select rGBM patients and may induce immunogenic cell death to stimulate anti-tumor immune responses. Our phase 2 study of re-irradiation with pembrolizumab among rGBM patients evaluated the efficacy an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::278882d2f7c45e9cca10ec3189d3770b
https://doi.org/10.1093/neuonc/noac209.250
https://doi.org/10.1093/neuonc/noac209.250